Manuscript gf crocin HDL.pdf (495.23 kB)
A pilot study of the effects of crocin on high-density lipoprotein cholesterol uptake capacity in patients with metabolic syndrome: a randomized clinical trial
journal contribution
posted on 2023-06-10, 01:39 authored by Maryam Saberi-Karimian, Hamideh Safarian-Bana, Elham Mohammadzadeh, Tooba Kazemi, Amin Mansoori, Hamideh Ghazizadeh, Sara Samadi, Irandokht Nikbakht-Jam, Mina Nosrati, Gordon FernsGordon Ferns, Habibollah Esmaily, Malihe Aghasizadeh, Majid Ghayour-MobarhanA randomized clinical trial high-density lipoprotein (HDL) cholesterol uptake capacity (CUC) is reduced in patients with metabolic syndrome (MetS). We have assessed the effect of crocin supplementation on HDL CUC in patients with MetS. Forty-four subjects with MetS were randomly allocated to one of two groups: one group received placebo and the other group received crocin at a dose of 30 mg (two tablets of 15 mg per day) for 8 weeks. Serum biochemical parameters were measured using an AutoAnalyzer BT3000 (BioTechnica). The modified CUC method is a cell free, simple, and high-throughput assay that used to evaluate HDL CUC of serum samples. The decision tree analysis was undertaken using JMP Pro (SAS) version 13. The mean age of the crocin and placebo groups were 38.97 ± 13.33 and 43.46 ± 12.77 years, respectively. There was a significant increase in serum HDL CUC in the crocin group compared to that of the placebo group in patients with MetS (p-value< 0.05). The decision tree analysis showed that serum HDL functionality was more important variable than HDL-C level in predicting patients with hypertension at baseline (p-value < 0.05). Crocin administration (30 mg for a period of 8 weeks) was found to improve serum HDL CUC in patients with MetS. Trial registration: IRCT2013080514279N1.
History
Publication status
- Published
File Version
- Accepted version
Journal
BioFactorsISSN
0951-6433Publisher
WileyExternal DOI
Issue
6Volume
47Page range
1032-1041Department affiliated with
- Division of Medical Education Publications
Full text available
- Yes
Peer reviewed?
- Yes
Legacy Posted Date
2021-11-08First Open Access (FOA) Date
2022-10-06First Compliant Deposit (FCD) Date
2021-11-08Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC